logo
explain how to read the page

The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers who have significant controls over the individuals in focus are always inapplicable. The offspring entities and appointments are those entities that the individuals in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Jump to: Offsprings
Parent entities and officers
Inapplicable
parent relation
Individuals in focus

De Rubertis, Francesco

    Related profiles found in government register
  • De Rubertis, Francesco
    Italian born in January 1970

    Resident in United Kingdom

    Registered addresses and corresponding companies
  • De Rubertis, Francesco
    born in January 1970

    Resident in United Kingdom

    Registered addresses and corresponding companies
  • De Rubertis, Francesco
    Italian born in January 1970

    Resident in Switzerland

    Registered addresses and corresponding companies
  • De Rubertis, Francesco
    Italian venture capitalist born in January 1970

    Resident in Switzerland

    Registered addresses and corresponding companies
  • De Rubertis, Francesco
    Italian born in January 1970

    Resident in England

    Registered addresses and corresponding companies
  • De Rubertis, Francesco
    Italian venture capital investor born in January 1970

    Resident in England

    Registered addresses and corresponding companies
  • De Rubertis, Francesco
    Italian born in January 1970

    Registered addresses and corresponding companies
  • De Rubertis, Francesco
    born in January 1970

    Resident in Switzerland

    Registered addresses and corresponding companies
  • Mr Francesco De Rubertis
    Italian born in January 1970

    Resident in Switzerland

    Registered addresses and corresponding companies
child relation
Offspring entities and appointments 42
  • 1
    ALDENA THERAPEUTICS (UK) LTD
    13540917
    Active Corporate (5 parents, 3 offsprings)
    Officer
    2022-12-07 ~ 2024-01-27
    IIF 24 - Director → ME
  • 2
    BPLETE LIMITED
    - now 13439199
    PROTEOMX LIMITED
    - 2023-11-17 13439199
    Active Corporate (4 parents)
    Officer
    2023-11-09 ~ now
    IIF 6 - Director → ME
  • 3
    CENTESSA PHARMACEUTICALS (OREXIA) LIMITED - now
    OREXIA THERAPEUTICS LIMITED - 2023-04-03
    OREXIA LIMITED
    - 2021-02-24 11607013
    Dissolved Corporate (13 parents)
    Officer
    2018-10-05 ~ 2021-01-29
    IIF 15 - Director → ME
  • 4
    CENTESSA PHARMACEUTICALS (UK) LIMITED - now
    CENTESSA LIMITED
    - 2022-11-22 13040752
    UNITED MEDICINES BIOPHARMA (MIDCO) LIMITED
    - 2021-02-17 13040752
    Active Corporate (13 parents, 8 offsprings)
    Officer
    2020-12-04 ~ 2021-02-19
    IIF 11 - Director → ME
  • 5
    CENTESSA PHARMACEUTICALS PLC
    - now 12973576 13040752
    CENTESSA PHARMACEUTICALS LIMITED
    - 2021-05-14 12973576 13040752
    UNITED MEDICINES BIOPHARMA LIMITED
    - 2021-02-17 12973576
    Active Corporate (16 parents, 9 offsprings)
    Officer
    2020-11-20 ~ 2026-06-24
    IIF 5 - Director → ME
  • 6
    CFS PRODUCTION LTD
    08991085
    Dissolved Corporate (3 parents)
    Officer
    2014-04-10 ~ dissolved
    IIF 37 - Director → ME
  • 7
    CRITICAL PRESSURE LIMITED
    10826367
    Liquidation Corporate (7 parents)
    Officer
    2018-01-01 ~ 2021-11-24
    IIF 19 - Director → ME
  • 8
    EGALET LIMITED
    07316221
    Dissolved Corporate (20 parents)
    Officer
    2010-07-29 ~ 2012-03-13
    IIF 2 - Director → ME
  • 9
    GRAEGIS PHARMACEUTICALS LIMITED
    13680871
    Active Corporate (9 parents)
    Officer
    2022-12-08 ~ 2023-10-14
    IIF 12 - Director → ME
  • 10
    GRANULAR THERAPEUTICS LIMITED
    - now 10650696
    ULTRAHUMAN FIVE LIMITED
    - 2021-02-04 10650696
    Active Corporate (7 parents)
    Officer
    2020-11-13 ~ 2023-10-18
    IIF 20 - Director → ME
  • 11
    IMHOTEX LIMITED
    12443280
    Active Corporate (5 parents)
    Officer
    2020-02-14 ~ now
    IIF 13 - Director → ME
  • 12
    INDEX VENTURES (UK) LLP
    - now OC344205
    INDEX VENTURE MANAGEMENT LLP
    - 2014-11-28 OC344205 04672531
    INDEX VENTURE MANAGEMENT SERVICES LLP
    - 2009-06-29 OC344205 04672531
    Active Corporate (17 parents, 1 offspring)
    Officer
    2009-06-29 ~ 2016-01-31
    IIF 4 - LLP Member → ME
  • 13
    INEXIA LIMITED
    11607985
    Dissolved Corporate (13 parents)
    Officer
    2018-10-05 ~ 2021-01-29
    IIF 16 - Director → ME
  • 14
    JANPIX LIMITED
    08709519
    Dissolved Corporate (14 parents)
    Officer
    2013-09-27 ~ 2019-09-06
    IIF 17 - Director → ME
  • 15
    KAERUS BIOSCIENCE LIMITED
    - now 10274924
    FRAXADEV LIMITED - 2016-11-23
    Active Corporate (12 parents)
    Officer
    2021-06-25 ~ now
    IIF 23 - Director → ME
  • 16
    LEVICEPT LTD
    08190142
    Active Corporate (12 parents)
    Officer
    2020-11-17 ~ now
    IIF 32 - Director → ME
  • 17
    LOCKBODY THERAPEUTICS LTD
    - now 10650186
    ULTRAHUMAN SIX LIMITED
    - 2020-11-15 10650186
    Dissolved Corporate (15 parents, 2 offsprings)
    Officer
    2020-11-13 ~ 2021-01-29
    IIF 25 - Director → ME
  • 18
    MEDICXI VENTURES (UK) LLP
    OC402437
    Active Corporate (9 parents)
    Officer
    2015-10-23 ~ now
    IIF 43 - LLP Designated Member → ME
    Person with significant control
    2022-03-31 ~ now
    IIF 44 - Ownership of voting rights - More than 25% but not more than 50% → OE
    IIF 44 - Right to surplus assets - More than 25% but not more than 50% → OE
    2019-11-26 ~ 2021-01-01
    IIF 45 - Right to surplus assets - More than 25% but not more than 50% → OE
    IIF 45 - Ownership of voting rights - More than 25% but not more than 50% → OE
  • 19
    METHUSELAH HEALTH UK LIMITED
    09209003
    Active Corporate (9 parents)
    Officer
    2014-09-09 ~ 2018-04-06
    IIF 18 - Director → ME
  • 20
    ONCOMET LIMITED
    08424564
    Dissolved Corporate (4 parents)
    Officer
    2013-05-20 ~ dissolved
    IIF 40 - Director → ME
  • 21
    OTTIMO PHARMA LIMITED
    - now 10650475
    ULTRAHUMAN EIGHT LIMITED
    - 2024-09-23 10650475
    Active Corporate (12 parents)
    Officer
    2020-11-13 ~ now
    IIF 21 - Director → ME
  • 22
    PANDEIA THERAPEUTICS LIMITED
    11463856
    Active Corporate (10 parents)
    Officer
    2019-09-19 ~ 2022-12-22
    IIF 9 - Director → ME
  • 23
    PANGENETICS B.V.
    FC026349
    Converted / Closed Corporate (4 parents)
    Officer
    2005-11-04 ~ now
    IIF 42 - Director → ME
  • 24
    PANGENETICS110 B.V.
    FC029348
    Active Corporate (8 parents)
    Officer
    2009-12-18 ~ now
    IIF 1 - Director → ME
  • 25
    PERFECT BALANCE BIO LIMITED
    12885832
    Active Corporate (4 parents)
    Officer
    2020-10-23 ~ now
    IIF 8 - Director → ME
  • 26
    ROUND EARTH THERAPEUTICS LIMITED
    - now 11966376
    G4X LTD
    - 2019-08-09 11966376
    Dissolved Corporate (7 parents)
    Officer
    2019-04-26 ~ 2022-05-10
    IIF 10 - Director → ME
  • 27
    SDS THERAPEUTICS LIMITED
    12719780
    Active Corporate (6 parents)
    Officer
    2020-12-18 ~ 2024-01-17
    IIF 7 - Director → ME
  • 28
    STEALTHYX THERAPEUTICS LIMITED
    04491233
    Liquidation Corporate (18 parents)
    Officer
    2014-12-02 ~ 2017-10-31
    IIF 38 - Director → ME
  • 29
    STX PHARMA LTD
    - now 08261024
    VULPEZ LIMITED
    - 2012-10-26 08261024
    Dissolved Corporate (8 parents)
    Officer
    2012-10-19 ~ dissolved
    IIF 3 - Director → ME
  • 30
    SUPERX LIMITED
    09865177
    Dissolved Corporate (13 parents)
    Officer
    2016-01-07 ~ 2016-12-14
    IIF 39 - Director → ME
  • 31
    ULTRAHUMAN FOUR LIMITED
    10650089
    Dissolved Corporate (13 parents)
    Officer
    2020-11-13 ~ 2021-01-29
    IIF 33 - Director → ME
  • 32
    ULTRAHUMAN FOURTEEN LIMITED
    10649858
    Dissolved Corporate (8 parents)
    Officer
    2020-11-13 ~ dissolved
    IIF 35 - Director → ME
  • 33
    ULTRAHUMAN LIMITED
    09885211
    Dissolved Corporate (10 parents)
    Officer
    2020-11-13 ~ 2023-06-30
    IIF 22 - Director → ME
  • 34
    ULTRAHUMAN NINE LIMITED
    10650506
    Dissolved Corporate (8 parents)
    Officer
    2020-11-13 ~ dissolved
    IIF 34 - Director → ME
  • 35
    ULTRAHUMAN ONE LIMITED
    10643582
    Dissolved Corporate (8 parents)
    Officer
    2020-11-13 ~ dissolved
    IIF 30 - Director → ME
  • 36
    ULTRAHUMAN SEVEN LIMITED
    10650641 10650000
    Dissolved Corporate (8 parents)
    Officer
    2020-11-13 ~ dissolved
    IIF 29 - Director → ME
  • 37
    ULTRAHUMAN TEN LIMITED
    10650470
    Dissolved Corporate (8 parents)
    Officer
    2020-11-13 ~ dissolved
    IIF 28 - Director → ME
  • 38
    ULTRAHUMAN THIRTEEN LIMITED
    10649837
    Dissolved Corporate (8 parents)
    Officer
    2020-11-13 ~ dissolved
    IIF 31 - Director → ME
  • 39
    ULTRAHUMAN TWELVE LIMITED
    10650550
    Dissolved Corporate (8 parents)
    Officer
    2020-11-13 ~ dissolved
    IIF 26 - Director → ME
  • 40
    ULTRAHUMAN TWO LIMITED
    10645698
    Dissolved Corporate (13 parents)
    Officer
    2020-11-13 ~ 2021-01-29
    IIF 27 - Director → ME
  • 41
    VIMELA THERAPEUTICS LIMITED
    13611487
    Active Corporate (9 parents)
    Officer
    2022-12-08 ~ 2023-10-18
    IIF 14 - Director → ME
  • 42
    Z FACTOR LIMITED
    09274181
    Dissolved Corporate (14 parents)
    Officer
    2020-10-20 ~ 2021-01-29
    IIF 36 - Director → ME
    2014-10-21 ~ 2017-03-02
    IIF 41 - Director → ME

The content of this website is protected by AgonGuard.

© 2022- Polylogarithmic Technology Ltd (Registered in England and Wales No. 14256313). All rights reserved.

Contains public sector information retrieved at 14 July 2026 and licensed under the Open Government Licence v3.0.